2021 STOCKHOLDER INFORMATION

The secure way to view our annual documents and vote your proxy.

Investor Materials

ANNUAL REPORT

View an enhanced version of our Annual Report.

PROXY STATEMENT

View an enhanced version of our Proxy Statement.

Request Paper Materials

You may request paper copies of the proxy material by phone, email or online.
To request by phone dial 866-648-8133.

Voting

YOUR VOTE IS IMPORTANT!
Please be sure to vote your proxy online now or by phone by dialing 866-390-9954.

Annual Meeting Details

DATE

$
May 12, 2021

    TIME

    $ 65,99
    10:30 AM Pacific Time

      LOCATION



      280 East Grand Avenue
      South San Francisco, CA 94080
      About Us

      Cytokinetics is a late-stage biopharmaceutical company focused on discovering, developing, and commercializing first-in-class muscle activators and next-in-class muscle inhibitors as potential treatments for people with debilitating diseases in which muscle performance is compromised and/or declining. Cytokinetics is developing small molecule drug candidates specifically engineered to impact muscle function and contractility.

      Powered by Donnelley Financial Solutions
      Copyright © 2021 Mediant Communications Inc. All Rights Reserved.